Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height

The biological processes controlling human growth are diverse, complex and poorly understood. Genetic factors are important and human height has been shown to be a highly polygenic trait to which common and rare genetic variation contributes. Weaver syndrome is a human overgrowth condition characterised by tall stature, dysmorphic facial features, learning disability and variable additional features. We performed exome sequencing in four individuals with Weaver syndrome, identifying a mutation in the histone methyltransferase, EZH2, in each case. Sequencing of EZH2 in additional individuals with overgrowth identified a further 15 mutations. The EZH2 mutation spectrum in Weaver syndrome shows considerable overlap with the inactivating somatic EZH2 mutations recently reported in myeloid malignancies. Our data establish EZH2 mutations as the cause of Weaver syndrome and provide further links between histone modifications and regulation of human growth.

[1]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[2]  R. Kuiper,et al.  Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes , 2010, Nature Genetics.

[3]  E. Dazert,et al.  mTOR signaling in disease. , 2011, Current opinion in cell biology.

[4]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[5]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[6]  N. Rahman,et al.  Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. , 2005, American journal of human genetics.

[7]  N. Rahman,et al.  Mutations in CEP57 cause mosaic variegated aneuploidy syndrome , 2011, Nature Genetics.

[8]  S. Knudsen,et al.  Prediction of human mRNA donor and acceptor sites from the DNA sequence. , 1991, Journal of molecular biology.

[9]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[10]  A. Chase,et al.  Aberrations of EZH2 in Cancer , 2011, Clinical Cancer Research.

[11]  D. Weaver,et al.  Weaver syndrome: autosomal dominant inheritance of the disorder. , 1998, American journal of medical genetics.

[12]  R. Copeland,et al.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.

[13]  A. Fryer,et al.  Autosomal dominant inheritance of Weaver syndrome. , 1997, Journal of medical genetics.

[14]  E. McCabe,et al.  Weaver syndrome: the changing phenotype in an adult. , 1989, American journal of medical genetics.

[15]  Yi Zhang,et al.  The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. , 2004, Current opinion in genetics & development.

[16]  M. Hung,et al.  The roles of EZH2 in cell lineage commitment. , 2011, American journal of translational research.

[17]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[18]  C. Eng,et al.  Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model , 2011, European Journal of Human Genetics.

[19]  Christopher B. Burge,et al.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.

[20]  S. Karlin,et al.  Prediction of complete gene structures in human genomic DNA. , 1997, Journal of molecular biology.

[21]  David W. Smith,et al.  A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. , 1974, The Journal of pediatrics.

[22]  H. Drexler,et al.  Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders , 2010, Nature Genetics.

[23]  Jamie K Teer,et al.  A mosaic activating mutation in AKT1 associated with the Proteus syndrome. , 2011, The New England journal of medicine.